Biotechnology Companies By Ebitda

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
EBITDA
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
EBITDAEfficiencyMarket RiskExp Return
1ABBV AbbVie Inc
14.91 B
 0.05 
 1.66 
 0.09 
2AMGN Amgen Inc
13.36 B
 0.19 
 1.80 
 0.35 
3GMAB Genmab AS
9.7 B
 0.13 
 2.01 
 0.26 
4REGN Regeneron Pharmaceuticals
5.32 B
 0.23 
 2.45 
 0.55 
5GILD Gilead Sciences
4.43 B
 0.14 
 1.45 
 0.20 
6BIIB Biogen Inc
3 B
 0.20 
 2.05 
 0.42 
7HLN Haleon plc
2.51 B
 0.18 
 1.27 
 0.22 
8INBX Inhibrx Biosciences,
1.7 B
 0.15 
 13.71 
 2.05 
9UTHR United Therapeutics
1.65 B
 0.16 
 1.76 
 0.29 
10GRFS Grifols SA ADR
1.48 B
(0.07)
 1.70 
(0.12)
11EXEL Exelixis
718.75 M
 0.12 
 2.63 
 0.31 
12HALO Halozyme Therapeutics
656.54 M
(0.06)
 1.84 
(0.10)
13BMRN Biomarin Pharmaceutical
650.53 M
 0.08 
 2.78 
 0.21 
14NBIX Neurocrine Biosciences
639.7 M
 0.04 
 2.06 
 0.08 
15ALKS Alkermes Plc
494.86 M
 0.03 
 2.27 
 0.06 
16VRTX Vertex Pharmaceuticals
486.3 M
 0.19 
 1.60 
 0.30 
17INCY Incyte
408.16 M
 0.16 
 2.07 
 0.33 
18SRPT Sarepta Therapeutics
316.89 M
 0.08 
 6.18 
 0.52 
19PTGX Protagonist Therapeutics
253.67 M
 0.12 
 4.46 
 0.53 
20CPRX Catalyst Pharmaceuticals
232.9 M
 0.19 
 1.94 
 0.38 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital. In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY